Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

28 September 2021: Original Paper

Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?

Jose C. Alonso-Escalante ABCDEF* , Lorenzo Machado ABDEF , Kiumars R. Tabar ABDE , Rachell Tindall DE , Ngoc Thai ADE , Tadahiro Uemura ACDEF

DOI: 10.12659/AOT.931648

Ann Transplant 2021; 26:e931648

Table 1 Recipient demographics, indication for transplantation, induction, and maintenance immunosuppression.

WARF (n=23)ASA/CLOP (n=32)CTL (n=197)p Value
Gender (M: F)6: 1721: 12118: 790.01
Mean age (y)6062550.01
Kidney disease (%)0.54
 Other* 22%12%28%
Induction Immunosuppression0.01
Maintenance Immunosuppression
 Other** 6%4%5%
* Includes IgA nephritis, lupus nephritis, Alport Syndrome, obstructive uropathy, drug-induced nephritis, cardiorenal syndrome, hepatorenal syndrome;
** includes belatacept, rapamycin, and solumedrol only.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358